| A Study of SYH2082 Injection in Healthy Participants (NCT07736404) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2026-04-13 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery. (NCT07519109) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2026-03-30 |
| A Study of SYH2069 Injection in Healthy Participants (NCT07736391) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2026-01-10 |
| A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes (NCT07026968) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-06-20 |
| A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis (NCT06943950) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-06-01 |
| Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients (NCT06562894) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-05-26 |
| A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder (NCT06958692) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-04-11 |
| Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer (NCT06571461) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-09-01 |
| A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients (NCT06511739) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-05-27 |
| A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy (NCT06383702) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-05-15 |
| A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) (NCT05753865) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2023-05-01 |
| An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis (NCT05858047) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2023-04-11 |
| A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus (NCT05707832) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2023-03-30 |
| Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors (NCT05728541) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2023-03-01 |
| A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors (NCT05609019) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2022-12-01 |
| Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects (NCT06360445) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2022-05-26 |
| A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer (NCT05274893) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2022-03-31 |
| Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma (NCT05047991) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-10-01 |
| Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer (NCT05009953) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-09-01 |
| A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD (NCT07239765) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-07-09 |
| The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects (NCT04880512) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-05-31 |
| Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance (NCT04728035) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-05-31 |
| Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC) (NCT04727853) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-03-01 |
| Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer. (NCT04482257) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2020-07-07 |